Brief: Acer Therapeutics And Relief Therapeutics Announce That The China National Intellectual Property Administration Issued Utility Model Patent 11,202,767 Covering ACER-001 Dosage Form
July 8 (Reuters) - Acer Therapeutics Inc ACER.O :
* ACER THERAPEUTICS AND RELIEF THERAPEUTICS ANNOUNCE THAT
THE
CHINA NATIONAL INTELLECTUAL PROPERTY ADMINISTRATION (CNIPA)
ISSUED UTILITY MODEL PATENT 11,202,767 COVERING ACER-001 DOSAGE
FORM
* ACER THERAPEUTICS INC - NEWLY ISSUED PATENT HAS AN
EXPIRATION
DATE OF AUGUST 24, 2031
Source text for Eikon: ID:nGNX3SvNCc
Further company coverage: ACER.O
Recent news on MindMaze Therapeutics Holding SA
See all newsBrief: Mindmaze Therapeutics Announces CHF 8.0 Million Strategic Equity Financing
Brief: Relief Therapeutics Shareholders Approve Business Combination With Neurox
Brief: Relief Therapeutics Receives FDA Response To Qidp Request For Rlf-Td011
Brief: Relief Therapeutics Says Interim CEO Michelle Lock Has Completed Her Transitional Mandate
Swiss stocks - Factors to watch on May 13